Title |
Neuroprotection for treatment of glaucoma in adults
|
---|---|
Published by |
John Wiley & Sons, Ltd, February 2013
|
DOI | 10.1002/14651858.cd006539.pub3 |
Pubmed ID | |
Authors |
Sena, Dayse F, Lindsley, Kristina |
Abstract |
Glaucoma is a heterogeneous group of conditions involving progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss. It is a leading cause of blindness worldwide. Open angle glaucoma (OAG), the commonest form of glaucoma, is a chronic condition that may or may not present with increased intraocular pressure (IOP). Neuroprotection for glaucoma refers to any intervention intended to prevent optic nerve damage or cell death. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 40% |
United Kingdom | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | <1% |
United States | 1 | <1% |
Unknown | 130 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 25 | 19% |
Student > Master | 19 | 14% |
Student > Ph. D. Student | 19 | 14% |
Other | 15 | 11% |
Student > Postgraduate | 12 | 9% |
Other | 31 | 23% |
Unknown | 11 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 67 | 51% |
Agricultural and Biological Sciences | 13 | 10% |
Nursing and Health Professions | 8 | 6% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Other | 17 | 13% |
Unknown | 16 | 12% |